[Pseudomembraneous enterocolitis in the treatment of patients with antibiotics].
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002701:Chloramphenicol / Q000009:adverse effects; D004405:Dysentery, Bacillary / Q000188:drug therapy; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced*; D004917:Erythromycin / Q000009:adverse effects; D006801:Humans; D007422:Intestines / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000009:adverse effects; D009761:Nystatin / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects; D011014:Pneumonia / Q000188:drug therapy; D011512:Proteus Infections; D012214:Rheumatic Heart Disease / Q000188:drug therapy; D013203:Staphylococcal Infections; D013307:Streptomycin / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D010406:Penicillins; D009761:Nystatin; D009268:Nalidixic Acid; D004917:Erythromycin; D002701:Chloramphenicol; D013752:Tetracycline; D013307:Streptomycin
Psevdomembranoznyĭ énterokolit pri lechenii bol'nykh antibiotikami.